Clinical Trials on Plaque Psoriasis in Canada

Total 401 results

PRCL Research Inc.

Completed

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

Psoriasis

Canada
Church & Dwight Company, Inc.

Completed

Clinical Efficacy Evaluation of Three Dentifrices

Dental Plaque | Gingival Inflammation and Bleeding

Canada
AnaptysBio, Inc.

Active, not recruiting

Long-Term Safety and Efficacy of Imsidolimab (ANB019) in Subjects With Generalized Pustular Psoriasis (GEMINI2)

Generalized Pustular Psoriasis

United States, Australia, France, Georgia, Germany, Korea, Republic of, Malaysia, Morocco, Poland, Romania, Spain, Taiwan, Thailand, Tunisia, Turkey
Galderma R&D

Completed

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

Psoriasis

United States, Canada
AnaptysBio, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (GEMINI1)

Generalized Pustular Psoriasis

United States, Australia, Georgia, Germany, Korea, Republic of, Malaysia, Morocco, Poland, Romania, Spain, Taiwan, Thailand, Tunisia, Turkey, Slovakia
Janssen Research & Development, LLC

Completed

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) (Discover-1)

Arthritis, Psoriatic

United States, Canada, Taiwan, Hungary, Malaysia, Germany, Czechia, Korea, Republic of, Russian Federation, Spain, Australia, Ukraine, Poland
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis

Carotid Artery Plaque

Canada
LEO Pharma

Completed

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

Psoriasis Vulgaris

United States, Canada, United Kingdom, Germany, Romania, France, Poland
GlaxoSmithKline

Completed

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Psoriasis

Canada, Poland
LEO Pharma

Completed

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

Psoriasis Vulgaris

United States, United Kingdom, Canada, Germany
Amgen

Completed

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Psoriasis

Australia, Canada, Hungary
Arcutis Biotherapeutics, Inc.

Completed

Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) (ARRECTOR)

Scalp Psoriasis

United States, Canada
Bausch Health Americas, Inc.

Completed

A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Psoriasis

Canada
University of British Columbia

Unknown

Efficacy of Red Light in the Treatment of Pigmentary Disorders

Vitiligo | Melasma | Lichen Planus Pigmentosus

Canada
LEO Pharma

Completed

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Psoriasis Vulgaris

United States, Canada, Germany, United Kingdom, France, Poland
NYU Langone Health
Janssen Scientific Affairs, LLC

Recruiting

Multi-Center PAMPA Study (PAMPA)

Psoriasis

United States, Canada
Pfizer

Completed

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE)

Arthritis, Psoriatic

Belgium, United States, Canada, Spain, Australia, Taiwan, Czechia, Hungary, Germany, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Brazil, Bulgaria
Bausch Health Americas, Inc.

Recruiting

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Psoriasis

United States, Panama
Janssen Research & Development, LLC

Recruiting

A Study of Guselkumab in Participants With Active Psoriatic Arthritis (APEX)

Arthritis, Psoriatic

Israel, United States, Germany, Taiwan, Korea, Republic of, Malaysia, China, Georgia, Poland, Spain, Philippines, Hungary, Italy, Canada, Bulgaria, Russian Federation, Serbia, Slovenia, Bosnia and Herzegovina, Greece, Ukraine, Cze... and more
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis (GESTURE)

Moderate to Severe Palmoplantar Psoriasis

Belgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
Probity Medical Research

Completed

Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

Arthritis | Arthralgia

Canada
Eli Lilly and Company

Terminated

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Psoriasis

Canada, United States
Dr. Amer Johri
Lantheus Medical Imaging

Completed

Early Detection of Cardiovascular Disease (VIBE)

Myocardial Infarction | Vascular Diseases | Atherosclerosis | Acute Coronary Syndrome | Cardiac Disease | Atheroma

Canada
Bausch Health Americas, Inc.

Recruiting

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Psoriasis

United States, Panama
Pfizer

Completed

Tofacitinib Ointment For Chronic Plaque Psoriasis

Psoriasis | Psoriasis Vulgaris

United States, Canada, Denmark, Poland
Ottawa Heart Institute Research Corporation
The Ottawa Hospital

Terminated

Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease

Stroke | Carotid Artery Stenosis | TIA

Canada
Innovaderm Research Inc.
Amgen

Completed

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Psoriasis

Canada
Astellas Pharma Global Development, Inc.
Kyowa Kirin Co., Ltd.

Completed

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

Canada, Australia, New Zealand
Queen's University

Completed

The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER (FOVUS-ER)

Chest Pain | Carotid Artery Plaque | Acute Coronary Syndrome

Canada
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (PAUSE)

Psoriasis

United States, Canada
Janssen Research & Development, LLC

Completed

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Psoriasis

United States, Canada, Poland
Pfizer

Completed

CP-690-550 Ointment For Chronic Plaque Psoriasis

Psoriasis

United States, Canada
Novartis Pharmaceuticals

Recruiting

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (V-PLAQUE)

Coronary Artery Disease

United States, Italy, Spain, France, Korea, Republic of, Hungary, Japan, Argentina, China, India, Belgium, Switzerland, United Kingdom, Canada, Australia, Brazil, Chile, Ireland
Innovaderm Research Inc.
Merck Sharp & Dohme LLC

Terminated

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Psoriasis

Canada
Abbott

Completed

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis (PRIDE)

Psoriasis

Canada
Amgen

Completed

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

Canada, Spain, United States, Germany
Amgen

Completed

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis (REFINE)

Psoriasis

Canada
Janssen Research & Development, LLC

Completed

An Exploratory Genetic Study in Participants With Psoriasis

Psoriasis

United States, Canada
MedImmune LLC

Completed

Long-Term Follow-Up Study of Psoriasis Patients

Psoriasis

Canada, United States, Belgium, France, Germany, Netherlands
LEO Pharma

Recruiting

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight (ADJUST)

Psoriasis Vulgaris

Belgium, Italy, Spain, Germany, Czechia, Greece, United Kingdom, France, Hungary, Poland, Netherlands
Bausch Health Americas, Inc.

Terminated

Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Psoriasis

United States, Australia, France, Canada, Denmark
Innovaderm Research Inc.

Completed

Development of a Method to Measure mRNA Levels in Skin Samples

Healthy | Psoriasis | Atopic Dermatitis Eczema

Canada
AbbVie

Recruiting

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO) (IMMagine)

Psoriasis

Canada, Belgium, Germany
Innovaderm Research Inc.
Abbott; Montreal Heart Institute

Completed

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis | Coronary Atherosclerosis | Vascular Inflammation

Canada
Amgen

Completed

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis (PSOR-003)

Psoriasis

Canada, Czechia, Germany
Bristol-Myers Squibb

Completed

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Australia, Canada, Mexico
AbbVie (prior sponsor, Abbott)
Cato Research; JSS Medical Research Inc.

Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis (Complete-PS)

Psoriasis

Canada
Abbott

Completed

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Psoriasis

United States, Canada
Abbott

Completed

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Psoriasis

United States, Canada

Clinical Trials on Plaque Psoriasis in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations